Category: diabetes
-
Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says
Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says When endocrinologist Mary Elizabeth Patti looks at a patient with type 2 diabetes who could benefit from weight loss, she sees more than body mass index and blood glucose levels. She also recognizes the challenges of social vulnerability, understanding how low income,…
-
STAT+: Trump administration restored funding for major diabetes study. The pause still set researchers back
STAT+: Trump administration restored funding for major diabetes study. The pause still set researchers back The Trump administration’s restoration of federal research funding to Columbia University has revived a landmark diabetes study that has tracked patients for nearly 30 years and vastly expanded understanding of the disease, its treatment, and its prevention. The study, which has been…
-
Why MAHA’s push on Coca-Cola and ice cream is ‘nutritionally hilarious’
Why MAHA’s push on Coca-Cola and ice cream is ‘nutritionally hilarious’ Pop quiz: What’s Coca-Cola with cane sugar and ice cream made with natural dyes? Answer: Coca-Cola and ice cream. Getting Coca-Cola to use cane sugar rather than corn syrup and ice cream manufacturers to stop their use of synthetic dyes are the latest achievements…
-
Nearly 1 in 3 teens have prediabetes, CDC finds, in ‘wake-up call’
Nearly 1 in 3 teens have prediabetes, CDC finds, in ‘wake-up call’ About 1 in 3 young people who are 12 to 17 years old have prediabetes, new national data show, putting them at risk not just for type 2 diabetes but also for heart disease and stroke. Developing chronic diseases early in life also…
-
Vaccine policy frays, CDC nominee in the hot seat, & obesity drug side effects
Vaccine policy frays, CDC nominee in the hot seat, & obesity drug side effects What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control and Prevention stand up to her boss? And can Amgen overcome its obesity drug’s side…
-
STAT+: GLP-1 drug helped type 1 diabetes patients keep healthy glucose levels and lose weight
STAT+: GLP-1 drug helped type 1 diabetes patients keep healthy glucose levels and lose weight Obesity drugs were first approved to treat type 2 diabetes, but there’s a growing movement to test them in type 1 diabetes, too. Research presented Monday at a large diabetes meeting showed some promise for this approach. Patients who took…
-
STAT+: Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results
STAT+: Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results Twelve people with type 1 diabetes who received an investigational off-the-shelf stem cell therapy were able to produce their own insulin and keep healthy blood glucose levels for at least one year, Vertex Pharmaceuticals said Friday. After three months, none of…
-
STAT+: HHS plans ‘bold, edgy’ campaign on ultra-processed foods and diabetes
STAT+: HHS plans ‘bold, edgy’ campaign on ultra-processed foods and diabetes The links between ultra-processed food and higher risk of diabetes will be the focus of the first wave of health secretary Robert F. Kennedy Jr.’s national “Take Back Your Health” campaign, according to a notice posted on a government site for contractors. The notice…
-
STAT+: As Omada goes public, executives reflect on why profits are elusive in digital health
STAT+: As Omada goes public, executives reflect on why profits are elusive in digital health Fourteen years after launching to help make a dent in the United States’ swelling chronic disease problem, Omada Health went public on Friday, raising $150 million at just over a $1 billion valuation. Before going public, Omada raised $450 million…
-
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in…